Beta Bionics, Inc.
Status: Publicly traded
Direct answer
Beta Bionics, Inc. is publicly traded on NASDAQ under the ticker BBNX.
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and...
Can you invest in Beta Bionics, Inc.?
Yes. Beta Bionics, Inc. is publicly traded on NASDAQ under the ticker BBNX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Beta Bionics, Inc.
Detailed equity research is provided by MarketSnap.